Literature DB >> 7574520

Interactions of biapenem with active-site serine and metallo-beta-lactamases.

A Felici1, M Perilli, B Segatore, N Franceschini, D Setacci, A Oratore, S Stefani, M Galleni, G Amicosante.   

Abstract

Biapenem, formerly LJC 10,627 or L-627, a carbapenem antibiotic, was studied in its interactions with 12 beta-lactamases belonging to the four molecular classes proposed by R. P. Ambler (Philos. Trans. R. Soc. Lond. Biol. Sci. 289:321-331, 1980). Kinetic parameters were determined. Biapenem was readily inactivated by metallo-beta-lactamases but behaved as a transient inhibitor of the active-site serine enzymes tested, although with different acylation efficiency values. Class A and class D beta-lactamases were unable to confer in vitro resistance toward this carbapenem antibiotic. Surprisingly, the same situation was found in the case of class B enzymes from Aeromonas hydrophila AE036 and Bacillus cereus 5/B/6 when expressed in Escherichia coli strains.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7574520      PMCID: PMC162731          DOI: 10.1128/AAC.39.6.1300

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  36 in total

1.  In vitro activity of LJC10,627, a new carbapenem antibiotic with high stability to dehydropeptidase I.

Authors:  K Ubukata; M Hikida; M Yoshida; K Nishiki; Y Furukawa; K Tashiro; M Konno; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

2.  Cloning and sequencing of the class B beta-lactamase gene (ccrA) from Bacteroides fragilis TAL3636.

Authors:  B A Rasmussen; Y Gluzman; F P Tally
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

3.  Automated analysis of enzyme inactivation phenomena. Application to beta-lactamases and DD-peptidases.

Authors:  F De Meester; B Joris; G Reckinger; C Bellefroid-Bourguignon; J M Frère; S G Waley
Journal:  Biochem Pharmacol       Date:  1987-07-15       Impact factor: 5.858

4.  Citrobacter diversus ULA-27 beta-lactamases. Improved purification and general properties.

Authors:  G Amicosante; A Oratore; N Franceschini; M Maccarrone; R Strom; M Galleni; J M Frère
Journal:  Biochem J       Date:  1988-09-15       Impact factor: 3.857

5.  Beta-lactamase production and biological characteristics in nitrosoguanidine induced Mycobacterium fortuitum mutants.

Authors:  L Fattorini; D Fiorentino; G Amicosante; N Franceschini; A Oratore; G Orefici
Journal:  Acta Leprol       Date:  1989

6.  A survey of the kinetic parameters of class C beta-lactamases. Cephalosporins and other beta-lactam compounds.

Authors:  M Galleni; G Amicosante; J M Frère
Journal:  Biochem J       Date:  1988-10-01       Impact factor: 3.857

7.  Imipenem as substrate and inhibitor of beta-lactamases.

Authors:  J Monks; S G Waley
Journal:  Biochem J       Date:  1988-07-15       Impact factor: 3.857

8.  Resistance caused by decreased penetration of beta-lactam antibiotics into Enterobacter cloacae.

Authors:  K Bush; S K Tanaka; D P Bonner; R B Sykes
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

9.  Beta-lactamase-mediated imipenem resistance in Bacteroides fragilis.

Authors:  G J Cuchural; M H Malamy; F P Tally
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

10.  Purification of beta-lactamases by affinity chromatography on phenylboronic acid-agarose.

Authors:  S J Cartwright; S G Waley
Journal:  Biochem J       Date:  1984-07-15       Impact factor: 3.857

View more
  6 in total

1.  Overexpression, purification, and characterization of the cloned metallo-beta-lactamase L1 from Stenotrophomonas maltophilia.

Authors:  M W Crowder; T R Walsh; L Banovic; M Pettit; J Spencer
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

2.  Interactions of beta-lactamases with sanfetrinem (GV 104326) compared to those with imipenem and with oral beta-lactams.

Authors:  G S Babini; M Yuan; D M Livermore
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

Review 3.  Biapenem.

Authors:  Caroline M Perry; Tim Ibbotson
Journal:  Drugs       Date:  2002       Impact factor: 9.546

4.  Biochemical characterization of the Pseudomonas aeruginosa 101/1477 metallo-beta-lactamase IMP-1 produced by Escherichia coli.

Authors:  N Laraki; N Franceschini; G M Rossolini; P Santucci; C Meunier; E de Pauw; G Amicosante; J M Frère; M Galleni
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

5.  Studies on ternary metallo-beta lactamase-inhibitor complexes using electrospray ionization mass spectrometry.

Authors:  Nathalie Selevsek; Andreas Tholey; Elmar Heinzle; Benoît M R Liénard; Neil J Oldham; Christopher J Schofield; Uwe Heinz; Hans-Werner Adolph; Jean-Marie Frère
Journal:  J Am Soc Mass Spectrom       Date:  2006-05-19       Impact factor: 3.109

6.  Probing substrate binding to metallo-beta-lactamase L1 from Stenotrophomonas maltophilia by using site-directed mutagenesis.

Authors:  Anne L Carenbauer; James D Garrity; Gopal Periyannan; Robert B Yates; Michael W Crowder
Journal:  BMC Biochem       Date:  2002-02-13       Impact factor: 4.059

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.